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Abstract
Recent advancements in medical entity linking
have been applied in the area of scientific lit-
erature and social media data. However, with
the adoption of telemedicine and conversational
agents such as Alexa in healthcare settings, medi-
cal name inference has become an important task.
Medication name inference is the task of mapping
user friendly medication names from a free-form
text to a concept in a normalized medication list.
This is challenging due to the differences in the
use of medical terminology from health care pro-
fessionals and user conversations coming from the
lay public. We begin with mapping descriptive
medication phrases (DMP) to standard medica-
tion names (SMN). Given the prescriptions of
each patient, we want to provide them with the
flexibility of referring to the medication in their
preferred ways. We approach this as a ranking
problem which maps SMN to DMP by ordering
the list of medications in the patients prescription
list obtained from pharmacies. Furthermore, we
leveraged the output of intermediate layers and
performed medication clustering. We present the
Medication Inference Model (MIM) achieving
state-of-the-art results. By incorporating medical
entities based attention, we have obtained further
improvement for ranking models.
1. Introduction
Medication names are extremely hard to pronounce for pa-
tients without a proper medical background. Thus, when
interacting with Alexa on medication names, patients with-
out this background may have many different ways to refer
to a medication (e,g. Bumetanide can be referred to as
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Figure 1. Different ways of how users interact with conversational
agents for medical queries
Bumetanide (generic name), Bumex (brand name), high
blood pressure pill (disease name)). On the other hand, pa-
tients with medical knowledge may use abbreviations or
specialized ways to refer to medication names. For example,
patients may use immune meds to refer to mycophenolate
mofetil hydrochloride in their prescription list.
In this paper, we describe a new problem about finding the
generic medication name (SMN: standardized medication
name) based on a patient’s description (DMP: descriptive
medication phrase) from a list of medications the patient
is consuming. According to our internal user research, in
the United States, patients with chronic diseases usually
take around four to five medications daily. This problem is
different from medical concept normalization (Zhu et al.,
2019) which tries to map a health-related entity mention
in a free-form text to a concept in a controlled vocabulary
(Miftahutdinov & Tutubalina, 2019) which is a generic con-
cept list rather than a patient specific prescription list and is
generally much longer.
We structure this as a ranking problem. Here we rank all
medications a patient is consuming based on the relationship
with the patient’s description and the one ranked highest
will be the inference result. We present a hard attention
based entity boosted CNN architecture achieving 4% over
earlier ranking methods.
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Furthermore, the mapping between SMN and DMP contains
the patient’s understanding of the medications, especially
from the usage perspective of the medications. Using latent
output from our model, we build a medication clustering
system which groups together medications with similar ef-
fects and disease treatments. The output is designed to aid
physicians to consider other medications as a substitution
for decreasing cost as well as helping patients distinguish
medications that are similar in their impression but should,
in reality, be used in different conditions. Moreover, with
clustering patients will have an intuitive understanding of
the relationship of the medications they are consuming. Our
contributions are as follows:
• We present a medical entity boosted architecture, Med-
ication Inference Model (MIM) achieving a 7%− 9%
improvement over strong BERT baselines.
• We benchmark against state-of-the-art ranking archi-
tectures, demonstrating robustness of our work.
• We present medication clustering results which group
together medications with similar effects and treat the
similar diseases.
2. Task Definition
Each example is represented as a tuple
(Q,P1, P2, ..., Pn, Y ), where Q = (q1, q2, ..., qlq ) is
a DMP, with a length lq, Pi = (p1, p2, ...plpi ) is a SMN,
with a length lpi , and Y = (y1, y2, ..., yn) is the label
representing the relationship between Q and P1, P2, ..., Pn.
Y and P have the same length. yi = 1 if Pi is the generic
medication name that Q is referring to, 0 otherwise.
Y Q = {q1(high), q2(blood), q3(pressure)}
y1 = 0 P1 = {p1(morphine), p2(suppository)}
y2 = 1 P2 = {p1(hydrochlorothiazide)}
y3 = 0 P3 = { }
It is possible that among P1, P2, ..., Pn, more than one medi-
cations may be referred to by Q. Thus,
∑n
i=0 yi = m where
m is the number of medications in P1, P2, ..., Pn that could
be referred by Q. Ideally, we should make it possible that
for the estimated Yˆ ,
∑n
i=0 yˆi > 1. In this paper, however,
we assume
∑n
i=0 yi = 1.
The clustering task is defined as grouping medications
across the prescriptions of different patients. i.e., we assign
each medication in (P1, P2, ..., PN ) to a group according to
the DMP Q associated with them.
3. Method
Instead of comparing n medications in each sample, we
begin with two. Each sample consists of (Q,P1, P2, Y ) and
the model must distinguish which SMN in P1, P2 the patient
is referring to by Q. To simplify, we assume only one of
(P1, P2) could be referred by Q. In practice, when there are
n (where n > 2) medications in a patient’s prescription we
run the model on all the combinations of the medications
and rank them accordingly.
3.1. Entity Boosted Two-Tower Neural Network
Motivated by the facial recognition problem, where the mod-
els evaluate the similarity between images of faces (Chopra
et al., 2005), we apply a Two-tower neural network to our
problem. We regard the DMP as the query of each medicine
and the SMNs as the medication candidates. The purpose is
to match the correct SMNs to the DMP provided.
Descriptions can often be verbose and can contain a large
amount of noise. To improve the robustness and reduce
noise, we have incorporated medical entity based hard at-
tention (Luong et al., 2015) using Amazon Web Services
Comprehend Medical (CM) (Bhatia et al., 2019) which is a
natural language processing service to perform entity and
relation extraction.
For each instance of data, we use the generic name as the
SMN in our model, and generate DMPs from free-form text
data that describe the usage of each medication in patient
friendly terms. To reduce the noise, we feed the description
to CM to extract entities. CM is able to extract relevant
medical information from unstructured text and classify ex-
tracted entities into five categories and 28 types. In this
work we use the entities marked with types “dx name” (di-
agnostic indicator), “treatment name”, “system organ site”,
“swap”, “generic name”, “procedure name”, “brand name”,
“test name” as DMPs.
3.1.1. MEDICATION INFERENCE MODEL
Figure 2 outlines the Medication Inference Model (MIM)
network. In this model, there are two different sets of un-
shared embedding weights, where one is used to embed
SMNs and the other DMP. We use convolutional (CNN)
layers (Kim, 2014) followed by pooling on top of the em-
bedding layer to get a vector representation of SMNs and
DNP separately. We use cosine distance to measure the
separation between the two SMNs and DMP.
3.1.2. BERT-BASED MODEL
It is natural to leverage models which prove to be successful
in solving question-answering problems to process our task.
Here, DMP are regarded as the patient’s query, with the n
SMNs as the answer candidates.
We concatenate the DMP output with different SMNs sepa-
rately and combine them into a BERT (Devlin et al., 2018)
based multi-choice model (Guo et al., 2019). The vector
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Figure 2. Medication Inference Model structure
representations of the [CLS] tokens are used to represent the
combinations of DMP with each SMN, and are fed into a
fully connected layer. Finally we use hinge loss for ranking
to compare the scale values with ground truth.
4. Experiments
4.1. Dataset and Evaluation Metrics
Synthetic Data Set The training and test dataset are gen-
erated from 2,683 medication descriptions from the FDB1
PEM (patient education module) dataset. FDB stands for
First DataBank which is a known drug database and medical
device database provider. Each PEM file contains a patient
facing medication description including medication generic
name, uses, warnings side effects etc.2.
The SMNs are collected from the generic name section and
DMPs are generated from the ”USES” section of the PEM
files using CM as described in Section 3.1.1. To evaluate
the effect of the entity extraction component, we generate
another DMP set by randomly drawing n-grams (where
n = [1, 2, 3, 4, 5]) from the ”USES” section of the PEM
1https://www.fdbhealth.com/
2CommonNames, Warning, Uses, HowToUse, SideEffects, Pre-
cautions, DrugInteractions, Overdose, Notes, MissedDose, Stor-
age, MedicAlert
files as a replacement for CM.
Next, we use the SMNs and DMPs collected to generate
our training and test sets. we generate each instance starting
with a DMP according to following steps.
1. For each DMP, we generate a positive SMNs set which
consist of SMNs extracted from the same PEM file
where the DMP is extracted from. It is possible that
one DMP may have multiple positive SMNs if the
DMP is a very general phrase. For example, the DMP
“high blood pressure” may have multiple SMNs since
many medications can be used to treat hypertension.
2. For each DMP, we also generate a negative SMN set.
The negative SMNs are all the medications covered by
the PEM files excluding the positive SMNs identified
above and should follow the constraint that the entities
extracted from the ”USES” section of the negative
SMNs’ PEM files should have no overlap with that of
the DMPs.
3. Each instance in the training and validation data set
consists of 1 positive SMN and n− 1 negative SMNs
randomly selected from the SMN sets described above.
The label of each instance is indicating which SMN is
positive.
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Number of candidates
Baseline Entity-based Attention
Model 2 3 4 5 2 3 4 5
NormalBert 69.7 54.7 46.6 42.7 79.7 72.7 62.4 62.5
BioBert 73.4 59.8 51.9 46.4 81.5 74.8 66.2 66.4
ClinicalBert 73.5 57.8 51.9 47.4 79.5 74.4 64.8 62.7
ARC-1 65.2 46.2 37.5 33.4 76.8 66.8 58.6 59.4
ARC-2 64.0 48.1 39.1 36.5 75.7 65.7 62.1 57.0
ConvKNRM 65.4 52.0 42.6 38.8 76.7 66.6 60.7 57.3
MatchLSTM 64.9 50.8 40.9 35.4 82.4 70.9 62.6 58.3
MatchPyramid 59.5 45.0 36.5 33.5 74.0 58.0 58.0 54.1
MIM 73.9 57.9 48.9 49.7 87.7 80.8 78.9 76.9
Table 1. Synthetic test set: For each model we report top1 accuracy including and excluding entity-based attention.
Upper limit for number of candidates
Model 2 3 4 5 10
BioBert 83.10 73.50 67.00 61.8 52.70
MIM 83.50 74.50 69.50 63.60 53.80
Table 2. Real test set: For each model we report top1 accuracy.
For the training and validation splits, n is set to 2 in step 3
above, which means there are two SMNs in each instance.
The training and validation data set contains 680K instances
and 70% of them are used for training and 30% for valida-
tion and testing.
For testing purposes, we generated four synthetic test sets
with n in step 3 set to 2, 3, 4, 5 separately to simulate the real
situations where patients with chronic disease in the U.S.
usually have four to five medications in their prescription
list at a time.
Real Data Set The real data set is generated based on 251
prescriptions collected from the i2b2 data set 3 which con-
tains the de-identified patient discharge summaries. Internal
human annotators generate DMPs for each medication in
the prescriptions. It is observed that in a real prescription,
multiple medications may serve the same purpose and a
general DMP could be used to refer to multiple medications
in a prescription. In our current experiment, we assume the
ground truth of each DMP is only the medication used to
generate the DMP in a prescription. In this way, we will get
the lower bound of the performance of the models. For test-
ing purpose, we limited the number of medications in each
prescription to be 10, 5, 4, 3, 2 respectively. For the test set
with 10 as max number of medications, we go through all
the 251 prescriptions and only select the prescriptions that
has less than 10 medications into our test set. We randomly
truncate the prescriptions in the 10 medication test set to 5,
4, 3, 2 medications as the other test sets. Further more, in
order to evaluate the situations where one DMP may refer
to multiple SMNs in a prescription, the annotators are cur-
rently working on labeling all the SMNs that a DMP could
refer to in a prescription and if the model outputs one of the
3https://portal.dbmi.hms.harvard.edu/projects/n2c2-nlp/
medications in the ground truth SMNs, the test sample will
be marked as success in future experiments.
We report accuracy as the main evaluation metric, i.e., the
correctness of selecting the positive SMN from n SMNs.
When evaluating on the test data, the model goes through all
pairwise combinations of the SMNs and ranks all the SMNs
accordingly.
4.2. Experimental Details
For the CNN-based model, we test multiple word em-
bedding models including 200-dimensional BioWordVec
(Zhang et al., 2019; Chen et al., 2018) and 300-dimensional
FastText word embeddings (Bojanowski et al., 2017) trained
with 3,466 articles from the Mayo Clinic. The two dimen-
sional CNN layer consisted of 200 filters with window size
2, strip as 1 and no regularization. Batch size is set to 150
and we observed model convergence after six epochs. For
the pre-trained language model, we leverage Clinical BERT
(Alsentzer et al., 2019), BioBERT (Lee et al., 2019), and
original BERT models (Devlin et al., 2018). We used the
default settings for all BERT models as provided by Devlin
et al. (2018). Batch size is set to 32, learning rate is set to
5 × 10−5 and dropout rate is set to 0.2. We observed the
model converged after 10 epochs. We trained and evaluated
all the models using a Tesla V100 GPU.
4.2.1. BASELINES
When evaluating the performance of our model, we compare
the medication name inference performance with baseline
models listed below.
• ARC-I (Hu et al., 2014): ARC-I finds the represen-
tation of each sentence with CNN layers, and then
compares the representation for the two sentences with
a multi-layer perceptron (MLP).
• ARC-II (Hu et al., 2014): ARC-II improves based on
ARC-I by calculating the interaction features between
sentences with CNN.
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• ConvKNRM (Dai et al., 2018): Conv-KNRM uses
CNN to represent n-grams of various lengths and soft
matches them in a unified embedding space. The n-
gram soft matches are then utilized by the kernel pool-
ing and a fully connected layer to generate the final
ranking score.
• MatchLSTM (Wang & Jiang, 2016): The
matchLSTM sequentially aggregates the match-
ing of the attention-weighted question to each token of
the answer and uses the aggregated matching result to
make a final prediction.
• MatchPyramid (Pang et al., 2016): MatchPyramid
generates a matching matrix which represents the simi-
larity between mention and candidate and then apply
CNN layers on top of the matrix followed by a MLP
layer to calculate the similarity score.
5. Results and Discussion
Table 1 provides the accuracy results for each model we
experimented with on the synthetic test data set. Number of
candidates represent test data sets with 2, 3, 4, 5 medications
in each test instance, as described in Section 4.1. We report
test results for each model with and without AWS Compre-
hend Medical as “Entity-based Attention” and “Baseline”
columns.
Table 1 demonstrates the robustness of MIM. We observe
that MIM and BERT based models outperform current state-
of-the-art models such as ARC-I and MatchPyramid across
a different number of candidates. Table 2 further compares
the performance of two best performing models on real test
set.
MIM outperforms BERT based models with a 7-9% im-
provement in accuracy. We believe the major reason for
this is that MIM, by encoding SMN and DMP separately, is
able to encode the representation in a more robust way in
comparison to BERT based models which concatenate the
representations together using a special separator token. We
also observe performance variation of BERT models based
on their pre-training. We found that domain specific pre-
training helps, giving 2-3% improvement when compared
to the baseline BERT.
We observe the entity-boosted description gives robust re-
sults across all the model settings achieving significant im-
provement in accuracy over non-entity based models. This
alleviates the problem of noise in the lengthy descriptions.
Furthermore we see that our MIM model, with a relatively
simpler CNN encoder as well as separate encoders for SMN
and DMP, has the distinct advantage of generating inference
results with low latency. This is ideal for real-time industrial
settings. According to our experiments, the average latency
for the MIM model for five medications is 10ms, while,
compared against BERT at 89ms.
5.1. Medication Clustering Result
We apply k-nearest neighbor (KNN) clustering based on
the CNN max pooling output from the Two-tower neural
network. The generic names of 2,683 medications are repre-
sented by vectors of 200 dimension. The number of clusters
of KNN is determined by a Silhouette analysis(Rousseeuw,
1987) with result given in Figure 3. The Silhouette analy-
sis shows that clustering performs better when number of
classes is 31.
Figure 3. Average Silhouette value for different number of clusters
Figure 4 shows the t-SNE visualization of the result where
2,683 medications are grouped into 31 clusters. The figure
illustrates that medications with same effects, treating same
disease or having similar drug types are mapped close to
each other.
Table 3 shows three examples of the clustering result. The
nearby SMNs are sampled from the same cluster which
example SMNs belong to and ranked according to their dis-
tance to the given SMN. The nature of the problem enables
and requires the inference model to group SMNs based
on multiple dimensions. We list examples from three di-
mensions and it is very natural for users to refer to their
medications by diagnosis, disease symptoms and drug type.
For example, coughing is a common symptom for multiple
diseases including the common cold, pulmonary diseases
such as pneumonia, and even from seasonal allergies. In
column (b), the model is able to cluster medications that
could relieve cough symptom of different underlying causes,
for example, promethazine and antihistamine are used to
treat allergies whereas zanamivir is used to treat and prevent
flu.
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(a) Diagnose (b) Symptom (c) Drug type
DMP high blood pressure,strokes, heart attacks cough, coughing antibiotic
example SMN amlodipine promethazine chloramphenicol
nearby SMNs
perindopril, ramipril,
trandolapril, quinapril,
enalapril, isradipine,
lisinopril, sacubitril,
aliskiren, eplerenone
dextromethorphan,
guaifenesin, expectorant,
antihistamine,
acetaminophen, hydrocodone,
zanamivir
polymyxin b, gentamicin,
cefotetan, spiramycin,
gatifloxacin, piperacillin,
cephalexin, cefoxitin,
ofloxacin
Table 3. Examples of the DMP/SMN match and clustering results
Figure 4. t-SNE visualization of the clusters
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6. Related Work
Earlier work on medical concept normalization (Zhu et al.,
2019) relied on lexicon based string matching and dictio-
nary lookup to map limited number of variations of text
to a pre-defined medical vocabulary (Aronson, 2001; Bren-
nan & Aronson, 2003). (Leaman et al., 2013) introduced
DNrom as the first pairwise learning ranking model that
compares associations between mentions and entities of var-
ious disease. (Limsopatham & Collier, 2016; Lee et al.,
2017) then further leveraged deep learning models, convolu-
tional neural network (Limsopatham & Collier, 2016) and
recurrent neural network models (Belousov et al., 2017)
trained on large corpus of medical articles etc.. Currently,
researchers enhanced the deep learning based model with
different model structure to incorporate context informa-
tion, better process out of vocabulary (OOV) words and take
advantages of interaction features from different semantic
levels (Luo et al., 2018; Miftahutdinov & Tutubalina, 2019;
Niu et al., 2019).
With the success of deep learning, many neural network
based models have been proposed for semantic matching,
and document ranking. Models such as ARC-I (Hu et al.,
2014) first compute the representation of the two sentences,
and then compute their relevance. Semantic/text matching
techniques fits well to solve the medical concept normal-
ization problems when the number of candidates is limited.
As listed in (Guo et al., 2019), recently researchers have
focused on developing deep learning models to solve docu-
ment retrieval, question answering, conversational response
ranking, and paraphrase identification (Guo et al., 2019)
problems and introduced state-of-the-art models such as
ARC-I (Hu et al., 2014), ARC-II (Hu et al., 2014), Con-
vKNRM (Dai et al., 2018), MatchLSTM (Wang & Jiang,
2016), MatchPyramid (Pang et al., 2016), Bert(Devlin et al.,
2018).
In recent years, natural language processing (NLP) tech-
niques have demonstrated increasing effectiveness in clin-
ical text mining (Bhatia et al., 2019) (Bhatia et al., 2019) .
Electronic health record (EHR) narratives, e.g., discharge
summaries and progress notes contain a wealth of medically
relevant information such as diagnosis information and ad-
verse drug events. Automatic extraction of such information
and representation of clinical knowledge in standardized
formats (Singh & Bhatia, 2019) could be employed for a
variety of purposes such as clinical event surveillance, deci-
sion support (Jin et al., 2018), pharmacovigilance, and drug
efficacy studies.
This paper describes a problem that is a combination of
the medical concept normalization and semantic matching
problem using medical entity based hard attention. The
nature of the problem presented in this paper requires the
solution be able to extract informations from short phrases
with limited context information.
7. Conclusion and Future Work
In this paper, we introduce a new problem common in the
development of medication voice interaction products. We
evaluate the accuracy of different solutions and show that
our entity boosted MIM outperform baseline models. The
specialty of this problem is that the context information is
very limited when compared against other NLP tasks and
the short length of the phrases prevent us from leveraging
other advanced techniques that rely on words relationship in
a phrase. The evaluation result also show that the problem
prefers simple model structure. Since the phrases structure
is very simple, the quality of word embeddings is more im-
portant in this problem and keeping the embedding weight
unchanged is important when the training data is not suf-
ficient enough to enhance the relationship between words
either due to the nature of the data or small sample sizes.
We also observe the discrepancy between synthetic collected
datasets from real patients. For example, the combinations
of the medicine on synthetic prescriptions may not be valid
from a practitioner’s or patient’s perspective. We plan to
further validate our model on real patient data to increase
practicality. Finally on top of comparing and evaluating on
two medications samples, we plan to experiment with more
medications in each sample in training to closer mimic real
world scenarios.
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